Physician profile
Scott P Conover
NPI 1437563673
$559.17
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.75 · 2021: $62.89 · 2022: $28.85 · 2023: $32.11 · 2024: $270 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $324.08 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $67.27 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $53.31 | 2019-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $35.15 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $19.39 | 2021 | |
| Merck Sharp & Dohme LLC | $16.90 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.98 | 2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $15.64 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Conover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.